Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma in a County Hospital System

Jun Yang Jiang, Chijioke Nze, Danielle Guffey, Rockbum Kim, Abiodun O. Ouyomi, Omar Rosales, Raka Bandyo, Akiva Diamond, Gustavo A. Rivero, Courtney Nicole Miller-Chism, Mark M. Udden, Martha P. Mims, Christopher R. Flowers, Ang Li, Purnima Sravanti Teegavarapu

Blood (2023) 142 (Supplement 1): 5140.

https://doi.org/10.1182/blood-2023-173927

Published: 2023

Journal Articles

A Novel JAK1 Inhibitor SHR0302 for Treatment of Chronic Graft-Verse-Host Disease: A Phase I Clinical Trial

Huiying Qiu, Qiaomei He, Xi Sun, Ying Wang, Jiahua Niu, Jun Yang, Chongmei Huang, Kun Zhou, Yin Tong, Yu Cai, Baoxia Dong, Liping Wan, Xianmin Song

Blood (2023) 142 (Supplement 1): 3554.

https://doi.org/10.1182/blood-2023-189174

Published: 2023

Journal Articles

Azacitidine Combined with Interferon α for Preemptive Treatment of AML/MDS after Allogeneic Peripheral Blood Stem Cell Transplantation：a Prospecitive Phase II Study

Chongmei Huang, Jun Yang, Yin Tong, Huiying Qiu, Kun Zhou, Xinxin Xia, Ying Zhang, Chang Shen, Liping Wan, Xianmin Song

Blood (2023) 142 (Supplement 1): 7055.

https://doi.org/10.1182/blood-2023-179892

Published: 2023

Journal Articles

TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice

Blood (2023) 141 (26): 3184–3198.

https://doi.org/10.1182/blood.2022018619

Published: 2023

Includes: Supplemental data

Journal Articles

Low-Dose Antithymocyte Globulin Plus Low-Dose Post-Transplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after Haploidentical Peripheral Blood Stem Cell Transplants: A Large Sample, Long-Term Follow-up Retrospective Study

Xingying Li, Jun Yang, Liping Wan, Yu CAI, Kun Zhou, Chongmei Huang, Yin Tong, Huiying Qiu, Xianmin Song

Blood (2022) 140 (Supplement 1): 10471–10472.

https://doi.org/10.1182/blood-2022-164983

Published: 2022

Journal Articles

Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improve the Survival of Patients with Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplantation

Zaihong Shen, Jun Yang, Yu CAI, Liping Wan, Chongmei Huang, Xiaowei Xu, Jiahua Niu, Xinxin Xia, Chang Shen, Huiying Qiu, Kun Zhou, Yin Tong, Xianmin Song

Blood (2022) 140 (Supplement 1): 4723.

https://doi.org/10.1182/blood-2022-163234

Published: 2022

Journal Articles

The Novel Role of Checkpoint Inhibitor PD-1H/VISTA in Osteoclast Cytoskeleton Regulation and Multiple Myeloma Bone Disease

Jing Fu, Shirong Li, Huihui Ma, Jun Yang, Lewis M Brown, Gabriel M. Pagnotti, Stephen J. Weiss, Markus Y. Mapara, Suzanne Lentzsch

Blood (2022) 140 (Supplement 1): 9930–9932.

https://doi.org/10.1182/blood-2022-169921

Published: 2022

Journal Articles

MAP4K2 Inhibition Reinforces the Iberdomide Sensitivity in MM Cells By Inducing IKZF1 Degradation through a CRBN Independent Mechanism

Shirong Li, Jing Fu, Jun Yang, Huihui Ma, Markus Y. Mapara, Christophe Marcireau, Suzanne Lentzsch

Blood (2022) 140 (Supplement 1): 4224–4225.

https://doi.org/10.1182/blood-2022-168314

Published: 2022

Journal Articles

MAP4K2 Silencing Overcomes IMiDs-Resistance in Multiple Myeloma

Shirong Li, Jing Fu, Jun Yang, Huihui Ma, Markus Y. Mapara, Christophe Marcireau, Suzanne Lentzsch

Blood (2021) 138 (Supplement 1): 2662.

https://doi.org/10.1182/blood-2021-151844

Published: 2021

Journal Articles

The Novel Role of Checkpoint Inhibitor PD-1H/VISTA in Osteoclast Activation and Multiple Myeloma Bone Disease

Jing Fu, Shirong Li, Huihui Ma, Jun Yang, Lewis M Brown, Gabriel M. Pagnotti, Stephen J. Weiss, Markus Y. Mapara, Suzanne Lentzsch

Blood (2021) 138 (Supplement 1): 1606.

https://doi.org/10.1182/blood-2021-145599

Published: 2021

Journal Articles

Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma

Shirong Li, Jing Fu, Jun Yang, Huihui Ma, Divaya Bhutani, Markus Y. Mapara, Christophe Marcireau, Suzanne Lentzsch

Blood (2021) 137 (13): 1754–1764.

https://doi.org/10.1182/blood.2020006334

Published: 2021

Includes: Supplemental data

Journal Articles

Impact of Insurance Status on Outcomes in Patients with AIDS-Defining Cancers

Jun Yang Jiang, Erin Reid, MD MS

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-138489

Published: 2020

Journal Articles

Gck Inhibition Is a Novel Therapeutic Strategy for RAS Mutated Multiple Myeloma and Overcomes Resistance to IMiDs

Shirong Li, Jing Fu, PhD, Jun Yang, MS, Markus Y Mapara, MD PhD, Christophe Marcireau, Suzanne Lentzsch, MD PhD

Blood (2020) 136 (Supplement 1): 24.

https://doi.org/10.1182/blood-2020-143418

Published: 2020

Journal Articles

Checkpoint Inhibitor PD-1H/VISTA Mediates MMP-13 Induced Osteoclast Activation and Multiple Myeloma Bone Disease

Jing Fu, PhD, Shirong Li, Huihui Ma, MD PhD, Jun Yang, MS, Gabriel M. Pagnotti, PhD, Stephen J. Weiss, MD PhD, Markus Y Mapara, MD PhD, Suzanne Lentzsch, MD PhD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-142528

Published: 2020

Journal Articles

Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell Disease

Eboni I. Lance, MD, Lisa Faulcon, MD, Zongming Fu, PhD, Jun Yang, PhD, Donna Whyte, MD, John J. Strouse, MD, PhD, Emily Barron-Casella, PhD, Kimberly Jones, Jennifer Van Eck, PhD, James F. Casella, MD, Allen Everett, MD

Blood (2019) 134 (Supplement_1): 2296.

https://doi.org/10.1182/blood-2019-122015

Published: 2019

Journal Articles

Diagnosis of Lung Complication in Allogeneic Stem Cell Transplantation By Combined Use of Multiple Methods through Bronchoscopic Alveolar Lavage

Su Li, master's degree, Xianmin Song, MD, Liping Wan, Chun Wang, Yin Tong, Master's degree, Chongmei Huang, MD, Xiaoqian Xu, Master's degree, Yu CAI, MD, Guogang Xie, MD, Rong Tang, MD, Yi Sun, PhD, Aihua Bao, MD, Jun Yang, MD

Blood (2019) 134 (Supplement_1): 4626.

https://doi.org/10.1182/blood-2019-127950

Published: 2019

Journal Articles

Low Dose Anti-Thymocyte Globulin Plus Low Dose Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Patients with Hematologic Malignancies: A Prospective, Phase II Study

Jun Yang, Jiang Jieling, Yu CAI, MD, Su Li, Liping Wan, Jun Zhu, Huixia Liu, Shan Shao, Haitao Bai, Chun Wang, Jiong Hu, MD, Xianmin Song

Blood (2018) 132 (Supplement 1): 4575.

https://doi.org/10.1182/blood-2018-99-110727

Published: 2018

Journal Articles

Favorable Overall Survival in Refractory Diffuse Large B-Cell Lymphoma When Responded to High-Dose Etoposide Mobilization Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation

Yu CAI, MD, Chun Wang, Xianmin Song, Liping Wan, Su Li, Jun Yang, Jieling Jiang, MD

Blood (2018) 132 (Supplement 1): 5758.

https://doi.org/10.1182/blood-2018-99-111868

Published: 2018

Journal Articles

TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia

Jun Yang, Francis R. LeBlanc, Shubha A. Dighe, Cait E. Hamele, Thomas L. Olson, David J. Feith, Thomas P. Loughran, Jr

Blood (2018) 131 (25): 2803–2815.

https://doi.org/10.1182/blood-2017-09-808816

Published: 2018

Includes: Supplemental data

Journal Articles

Blockade of IL-2 and IL-15 Gamma Chain Receptor Signaling Decreases Leukemic Cell Viability in T-Cell Large Granular Lymphocyte Leukemia and Adult T-Cell Leukemia

Tracy Tiffany Wang, BS, Jun Yang, MD, Yong Zhang, PhD, Meili Zhang, PhD, Kevin C Conlon, MD, Yutaka Tagaya, B.M., PhD, Thomas L Olson, PhD, David J Feith, PhD, Nazli Azimi, Pharm.D., PhD, Thomas A. Waldmann, MD, Thomas P Loughran, Jr., MD

Blood (2017) 130 (Supplement 1): 3585.

https://doi.org/10.1182/blood.V130.Suppl_1.3585.3585

Published: 2017

NARROW

Clinical Outcomes of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma in a County Hospital System

A Novel JAK1 Inhibitor SHR0302 for Treatment of Chronic Graft-Verse-Host Disease: A Phase I Clinical Trial

Azacitidine Combined with Interferon α for Preemptive Treatment of AML/MDS after Allogeneic Peripheral Blood Stem Cell Transplantation：a Prospecitive Phase II Study

TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice

Low-Dose Antithymocyte Globulin Plus Low-Dose Post-Transplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after Haploidentical Peripheral Blood Stem Cell Transplants: A Large Sample, Long-Term Follow-up Retrospective Study

Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improve the Survival of Patients with Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplantation

The Novel Role of Checkpoint Inhibitor PD-1H/VISTA in Osteoclast Cytoskeleton Regulation and Multiple Myeloma Bone Disease

MAP4K2 Inhibition Reinforces the Iberdomide Sensitivity in MM Cells By Inducing IKZF1 Degradation through a CRBN Independent Mechanism

MAP4K2 Silencing Overcomes IMiDs-Resistance in Multiple Myeloma

The Novel Role of Checkpoint Inhibitor PD-1H/VISTA in Osteoclast Activation and Multiple Myeloma Bone Disease

Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma

Impact of Insurance Status on Outcomes in Patients with AIDS-Defining Cancers

Gck Inhibition Is a Novel Therapeutic Strategy for RAS Mutated Multiple Myeloma and Overcomes Resistance to IMiDs

Checkpoint Inhibitor PD-1H/VISTA Mediates MMP-13 Induced Osteoclast Activation and Multiple Myeloma Bone Disease

Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell Disease

Diagnosis of Lung Complication in Allogeneic Stem Cell Transplantation By Combined Use of Multiple Methods through Bronchoscopic Alveolar Lavage

Low Dose Anti-Thymocyte Globulin Plus Low Dose Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Patients with Hematologic Malignancies: A Prospective, Phase II Study

Favorable Overall Survival in Refractory Diffuse Large B-Cell Lymphoma When Responded to High-Dose Etoposide Mobilization Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation

TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia

Blockade of IL-2 and IL-15 Gamma Chain Receptor Signaling Decreases Leukemic Cell Viability in T-Cell Large Granular Lymphocyte Leukemia and Adult T-Cell Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only